The antimicrobial plastics market comprises various plastic products infused with antimicrobial agents to inhibit the growth of microorganisms. These plastics are used in a wide range of applications including medical devices & equipment, toilet seats, food packaging, and consumer goods among others. Their self-sanitizing nature finds extensive usage in healthcare settings and other places with high microbial activity.

The global antimicrobial plastics market is estimated to be valued at US$ 37.35 Bn in 2024 and is expected to exhibit a CAGR of 9.8% over the forecast period 2024 to 2031.
Key players operating in the antimicrobial plastics market are F. Hoffmann-La Roche Ltd, Biocryst Pharmaceuticals Inc., Bristol-Myers Squibb Company, Kyowa Kirin Co., Ltd., Genmab A/S, Seagen Inc., GlaxoSmithKline plc., Johnson and Johnson Private Limited, Elorac, Acrotech Biopharma, Merck and Co. Inc., Novartis AG, SHIONOGI & Co., Ltd., Spectrum Pharmaceuticals Inc., and Bausch Health Companies Inc.
Key Takeaways
Key players
Key players operating in the antimicrobial plastics market are focusing on new product launches and strategic collaborations to gain a competitive edge and expand their global reach. For instance, in 2021 Biocryst Pharmaceuticals Inc. launched its oral, once-daily oral medicine BRINAVESS to treat uncontrolled rare illnesses.
Growing Demand
The increasing awareness about health and well-being among consumers has propelled the need for safer and more hygienic products. This has boosted the demand for Antimicrobial Plastics Market Size from various end-use industries like consumer goods and medical devices. Moreover, the COVID-19 outbreak further underscored the importance of infection control via antimicrobial surfaces.
Global Expansion
Leading market players are focusing on expanding their manufacturing plants and distribution networks in high-growth regions like Asia Pacific and South America. For example, F. Hoffmann-La Roche Ltd strengthened its market presence in China by opening a new pharmaceutical plant in Shanghai in 2019. This will help the company address the increasing requirements of antimicrobial products in these regions.
Market Drivers
One of the key drivers for the antimicrobial plastics market is the growing need for infection control and prevention across various end-use verticals including healthcare, packaging, consumer goods, and construction. The ability of these plastics to curb the spread of viruses and bacteria on high-touch surfaces has increased their applicability in domains that demand high standards of hygiene. Furthermore, the rising awareness about environmental protection and public health has also boosted the demand for eco-friendly antimicrobial alternatives to traditional chemicals and composites.